Figure S3 from Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth

Authors :: Akira Kikuchi
Satoshi Obika
Takumi Fukumoto
Eiichi Morii
Satoshi Nojima
Hidetoshi Eguchi
Takehiro Noda
Tsunekazu Mizushima
Naotsugu Haraguchi
Tomoo Itoh
Toshihiko Yoshida
Hidetoshi Gon
Yuuya Kasahara
Shinsuke Fujii
Hirokazu Kimura
Suguru Hirota
Shinji Matsumoto
Takeshi Harada
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: YAP/TAZ is not a downstream target of ARL4C in HCC cells.

Tools